162 related articles for article (PubMed ID: 30509168)
1. The STRIPAK complex components FAM40A and FAM40B regulate endothelial cell contractility via ROCKs.
Suryavanshi N; Furmston J; Ridley AJ
BMC Cell Biol; 2018 Dec; 19(1):26. PubMed ID: 30509168
[TBL] [Abstract][Full Text] [Related]
2. A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.
Goudreault M; D'Ambrosio LM; Kean MJ; Mullin MJ; Larsen BG; Sanchez A; Chaudhry S; Chen GI; Sicheri F; Nesvizhskii AI; Aebersold R; Raught B; Gingras AC
Mol Cell Proteomics; 2009 Jan; 8(1):157-71. PubMed ID: 18782753
[TBL] [Abstract][Full Text] [Related]
3. STRIPAK components determine mode of cancer cell migration and metastasis.
Madsen CD; Hooper S; Tozluoglu M; Bruckbauer A; Fletcher G; Erler JT; Bates PA; Thompson B; Sahai E
Nat Cell Biol; 2015 Jan; 17(1):68-80. PubMed ID: 25531779
[TBL] [Abstract][Full Text] [Related]
4. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
5. STRIPAK complexes: structure, biological function, and involvement in human diseases.
Hwang J; Pallas DC
Int J Biochem Cell Biol; 2014 Feb; 47():118-48. PubMed ID: 24333164
[TBL] [Abstract][Full Text] [Related]
6. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
You C; Zhao K; Dammann P; Keyvani K; Kreitschmann-Andermahr I; Sure U; Zhu Y
J Cell Mol Med; 2017 Sep; 21(9):1848-1858. PubMed ID: 28371279
[TBL] [Abstract][Full Text] [Related]
7. ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis.
Herberich SE; Klose R; Moll I; Yang WJ; Wüstehube-Lausch J; Fischer A
PLoS One; 2015; 10(12):e0145304. PubMed ID: 26698571
[TBL] [Abstract][Full Text] [Related]
8. Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.
Shenkar R; Shi C; Rebeiz T; Stockton RA; McDonald DA; Mikati AG; Zhang L; Austin C; Akers AL; Gallione CJ; Rorrer A; Gunel M; Min W; De Souza JM; Lee C; Marchuk DA; Awad IA
Genet Med; 2015 Mar; 17(3):188-196. PubMed ID: 25122144
[TBL] [Abstract][Full Text] [Related]
9. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
10. Cerebral cavernous malformation proteins at a glance.
Draheim KM; Fisher OS; Boggon TJ; Calderwood DA
J Cell Sci; 2014 Feb; 127(Pt 4):701-7. PubMed ID: 24481819
[TBL] [Abstract][Full Text] [Related]
11. PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.
Stamatovic SM; Sladojevic N; Keep RF; Andjelkovic AV
Acta Neuropathol; 2015 Nov; 130(5):731-50. PubMed ID: 26385474
[TBL] [Abstract][Full Text] [Related]
12. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
13. Structure-function analysis of core STRIPAK Proteins: a signaling complex implicated in Golgi polarization.
Kean MJ; Ceccarelli DF; Goudreault M; Sanches M; Tate S; Larsen B; Gibson LC; Derry WB; Scott IC; Pelletier L; Baillie GS; Sicheri F; Gingras AC
J Biol Chem; 2011 Jul; 286(28):25065-75. PubMed ID: 21561862
[TBL] [Abstract][Full Text] [Related]
14. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
[TBL] [Abstract][Full Text] [Related]
16. Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells.
Riolo G; Ricci C; Battistini S
Cells; 2021 Mar; 10(3):. PubMed ID: 33810005
[TBL] [Abstract][Full Text] [Related]
17. CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.
Draheim KM; Li X; Zhang R; Fisher OS; Villari G; Boggon TJ; Calderwood DA
J Cell Biol; 2015 Mar; 208(7):987-1001. PubMed ID: 25825518
[TBL] [Abstract][Full Text] [Related]
18. Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening.
Schwefel K; Spiegler S; Ameling S; Much CD; Pilz RA; Otto O; Völker U; Felbor U; Rath M
J Cell Mol Med; 2019 Mar; 23(3):1771-1783. PubMed ID: 30549232
[TBL] [Abstract][Full Text] [Related]
19. Mural Cell-Specific Deletion of Cerebral Cavernous Malformation 3 in the Brain Induces Cerebral Cavernous Malformations.
Wang K; Zhang H; He Y; Jiang Q; Tanaka Y; Park IH; Pober JS; Min W; Zhou HJ
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2171-2186. PubMed ID: 32640906
[TBL] [Abstract][Full Text] [Related]
20. CCM3 and cerebral cavernous malformation disease.
Wang K; Zhou HJ; Wang M
Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
